.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Ceres is stocked at 262 licensed dispensaries across Washington, with the deepest coverage in Seattle, Tacoma, Spokane, Vancouver, and Everett. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Ceres concentrated 57.43% of August 2026 sales in Topical, up 3.43% month over month but down 6.77% year over year, while Edible held 36.46% with a 2.09% MoM lift and a 10.87% YoY decline; together these two categories account for 93.89% and anchor a brand-wide YoY sales change of -9.06% alongside a 1.70% YoY rise in average price. Smaller lines diverged: Tincture & Sublingual at 3.12% share climbed 6.20% MoM but fell 27.83% YoY, Capsules at 2.74% dropped 17.43% MoM and 3.99% YoY, while Vapor Pens at 0.14% surged 15.17% MoM despite a 48.59% YoY contraction and Concentrates, though just 0.11% share, jumped 67.67% MoM with no YoY baseline; this mix implies reliance on Topical to buffer declines elsewhere and signals early testing in peripheral categories to probe incremental growth without diluting the core.
With a number 1 rank in Topical in Washington and Topical commanding 57.43% share, the brand is positioned as a category specialist whose modest MoM gains in Topical (+3.43%) and Edible (+2.09%) can offset steeper YoY losses in Tincture & Sublingual (-27.83%) and Vapor Pens (-48.59%), concentrating pricing power where the 25.29 average Topical price outpaces the 10.66 Edible level. The sharp 17.43% MoM pullback in Capsules alongside a 67.67% MoM spike in Concentrates indicates portfolio pruning and experimentation at the margins, implying a strategy to defend the Topical leadership while selectively reallocating shelf space toward faster-moving or higher-margin micro-lines to stabilize total sales despite a -9.06% YoY brand decline.
Competitive Landscape
Ceres sits at rank #1 in WA Topical in August 2026, unchanged from #1 year over year, while maintaining #1 over the past three months and marking its peak at #1 in August 2026; in contrast, Agro Couture improved its position from #3 to #2 with a 2.9% year-over-year sales increase, and Double Delicious slipped from #2 to #3 alongside a 38.4% year-over-year sales decline. Additionally, Fairwinds held at #4 with a 26.7% sales contraction year over year, while SnacMe rose from #6 to #5 on 13.2% growth; the combined upward and downward shifts among immediate followers imply Ceres’s unbroken #1 rank is anchored less by sudden expansion and more by stability against mixed competitor momentum.
Notable Products
The steepest movement in August 2026 was the Sativa Assorted Fruit Chews 10-Pack (100mg) dropping -28.3% MoM while sliding to rank 10, contrasted by Indica Assorted Fruit Chews 10-Pack (100mg) climbing +24.1% MoM to rank 8. At the top, CBD/THC/CBG/CBN 1:1 Xtra Strength Dragon Balm Roll on (1000mg CBD, 1150mg THC, 75mg CBG, 75mg CBN, 3.4oz, 100ml) held rank 1 with +2.5% MoM as the adjacent CBG/CBN/CBD/THC 1:1 Gold Maximum Strength Dragon Pain Relieving Roll on (1300mg CBG, 100mg CBN, 100mg CBD, 1500mg THC, 3.4oz) sat at rank 2 on +1.8% MoM, together implying the Topical duo continues to anchor the lineup around premium multi-cannabinoid formats. Four of the top ten are Edible SKUs, but with Sativa Sea Salted Caramel Chocolate Balls 10-Pack (100mg) falling -10.3% MoM at rank 3 and CBD/THC 1:1 Sativa Assorted Fruit Chews 10-Pack (100mg CBD, 100mg THC) rising +17.6% at rank 5, the edible mix tilts toward fruit chews over confections, signaling a pivot toward consistent cannabinoid-balanced snacking. With the Topical leaders contributing over $315,000 in August 2026 and Edibles splitting between growth in fruit chews and declines in select sativa items, the product mix points to Ceres concentrating on multi-cannabinoid Topicals while pruning or repositioning underperforming Sativa Edibles.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
